How has artificial intelligence impacted COVID-19 drug repurposing and what lessons have we learned?

Journal: Expert opinion on drug discovery
Published Date: Sep 26, 2022

Abstract

No abstract available for this article.

Authors

  • E Sila Ozdemir
    Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
  • Srivathsan V Ranganathan
    Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
  • Ruth Nussinov
    Computational Structural Biology Section, Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702, USA.

Keywords

External Resources

Popular Topics
Recent Journals